Metabolic syndrome among type 2 Diabetes Mellitus patients in Ethiopia: a systematic review and meta-analysis

被引:0
作者
Charkos, Tesfaye Getachew [1 ]
Lemi, Hunde [1 ]
Arero, Godana [1 ]
Getnet, Menberu [2 ]
机构
[1] Adama Hosp Med Coll, Sch Publ Hlth, Adama, Ethiopia
[2] Adama Hosp Med Coll, Dept Internal Med, Adama, Ethiopia
来源
FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE | 2024年 / 5卷
关键词
diabetes mellitus; metabolic syndrome; prevalence; meta-analysis; ethiopia; PREVALENCE; DEFINITION;
D O I
10.3389/fcdhc.2024.1437288
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The prevalence of metabolic syndrome among type 2 diabetes mellitus patients was inconsistent in Ethiopia. Therefore, we aimed to pool the prevalence of metabolic syndrome among type 2 diabetes mellitus patients using a systematic review and meta-analysis. Methods PubMed, EMBASE, and Cochrane Library databases were systematically searched for relevant articles from January 2023 to January 2024. In addition, a manual search was conducted using published articles' reference lists. The random-effects model was used to pool prevalence from individual studies. All analysis was performed using R software. Results A total of nine articles met the inclusion criteria and were included in the analysis. The participants' average age was 59.8 +/- 3.84 years old. The pooled prevalence of MetS in T2DM patients was 53% (95% CI: 47-58). A significant heterogeneity was found across the included studies (P < 0.001, I2 = 92%). Based on diagnostic criteria, the prevalence of MetS in T2DM patients was 49% (95% CI: 43-56), 57% (95% CI: 47-67), 57% (95% CI: 43-77), and 44% (95% CI: 20-58) based on IDF, NCEP-ATP II, 2009 harmonized, and WHO criteria. By gender, the prevalence of MetS in T2DM patients was 48% (95% CI: 28-68) for females and 32% (95% CI: 17-49) for males. Conclusion This study found that over half of type 2 diabetes mellitus patients in Ethiopia are affected by metabolic syndrome, with a higher prevalence observed in females compared to males. The NCEP-ATP II and 2009 harmonized criteria consistently yielded similar prevalence rates of metabolic syndrome. These findings highlight the importance of educating T2DM patients on preventing and managing cardiovascular disease and its related complications.
引用
收藏
页数:9
相关论文
共 48 条
  • [31] American Heart Association
  • [32] World Heart Federation
  • [33] International Atherosclerosis Society
  • [34] and International Association for the Study of Obesity, Circulation, 120, (2009)
  • [35] Alberti K.G., Zimmet P.Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabetes Med, 15, (1998)
  • [36] Wells G.A., Et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses, 3rd Symposium on Systematic Reviews: Beyond the Basics, (2000)
  • [37] DerSimonian R., Laird N., Meta-analysis in clinical trials, Control Clin. Trials, 7, (1986)
  • [38] Barendregt J.J., Doi S.A., Lee Y.Y., Norman R.E., Vos T., Meta-analysis of prevalence, J. Epidemiol. Community Health, 67, (2013)
  • [39] Cochran W.G., The combination of estimates from different experiments, Biometrics, 3, (1954)
  • [40] Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G., Measuring inconsistency in meta-analyses, BMJ, 327, (2003)